255 results
8-K
EX-99.1
2odyat xw4ts
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm
8-K
EX-10.2
qffa2wtlmnhabye1
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.1
te07vu7s
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.2
qe00kb8kgrqe
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
pdvosjd 8na39akdwg3g
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
slktypcf6m4u ve
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.2
bb2a736c5lw jilcz7pk
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am